GlassScriptPhysician profile
Daryl F Remick
NPI 1174956478
$1,631.93
in general payments reported to CMS, 2019-2025
38 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $223 · 2021: $410 · 2022: $199 · 2023: $214 · 2024: $316 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $288.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $153.38 | 2021-2025 | |
| Medtronic USA, INC. | $102.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $78.48 | 2019-2022 | |
| Tris Pharma INC | $65.83 | 2023-2024 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $63.54 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $58.26 | 2019-2023 | |
| Neos Therapeutics, LP | $54.27 | 2023-2024 | Adzenys Xr-Odt |
| Antares Pharma, INC. | $54.24 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $48.25 | 2022 | |
| Amgen INC. | $44.73 | 2019-2024 | Otezla |
| Amarin Pharma, INC. | $39.78 | 2019 | |
| Glaxosmithkline, LLC. | $39.15 | 2020-2022 | |
| Baxter Healthcare | $38.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Abbott Laboratories | $34.45 | 2023-2024 | Freestyle Libre |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $32.52 | 2021 | |
| Eisai INC. | $32.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $32.25 | 2020-2022 | |
| Dexcom, INC. | $29.93 | 2021-2023 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $29.74 | 2021-2024 | Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $28.66 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $25.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $24.57 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.63 | 2024 | |
| Esperion Therapeutics, INC. | $20.75 | 2021 | |
| Hologic Sales and Service, LLC | $18.80 | 2023 | Aptima |
| Lilly USA, LLC | $18.77 | 2022 | |
| Corcept Therapeutics | $18.44 | 2025 | Korlym |
| Mylan Pharmaceuticals INC. | $14.58 | 2021 | |
| Currax Pharmaceuticals LLC | $14.38 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.07 | 2021 | |
| Allergan, INC. | $13.95 | 2019 | |
| Aytu Biopharma, INC. | $13.74 | 2019 | |
| Merck Sharp & Dohme LLC | $13.41 | 2020 | |
| Horizon Therapeutics Plc | $12.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.59 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.11 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Remick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.